Emergency Alcohol Septal Ablation for Cardiogenic Shock in Obstructive Hypertrophic Cardiomyopathy
Huseyin E Arman1, Omar Nahhas1, Michael R Kendall2
1Aurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St Luke's Medical Centers, Milwaukee, Wisconsin, USA.
Emergency alcohol septal ablation (ASA) effectively treats severe left ventricular outflow tract obstruction (LVOTO) in hypertrophic cardiomyopathy (HCM) patients experiencing hemodynamic instability. Combining ASA with mavacamten offers sustained improvement for high-risk HCM cases.
Area of Science:
- Cardiology
- Interventional Cardiology
- Hypertrophic Cardiomyopathy Research
Background:
- Left ventricular outflow tract obstruction (LVOTO) in hypertrophic cardiomyopathy (HCM) can lead to severe complications, including cardiogenic shock.
- Patients with advanced HCM are at high risk for acute hemodynamic decompensation due to LVOTO.
Observation:
- A 74-year-old patient with advanced HCM presented with acute hemodynamic instability caused by severe LVOTO.
- The patient was managed with emergency alcohol septal ablation (ASA).
Findings:
- Emergency ASA led to rapid hemodynamic stabilization and symptom resolution in the patient.
- The patient experienced sustained improvement following ASA with the adjunctive use of mavacamten.
Implications:
- Emergency ASA is a critical, minimally invasive treatment option for high-risk HCM patients with acute LVOTO and hemodynamic instability, especially when surgery is not feasible.
- Combined procedural (ASA) and pharmacologic (mavacamten) therapies optimize outcomes in managing complex HCM cases.
More Related Videos
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiopulmonary Resuscitation III: AED Use
Cardiomyopathy IV: Restrictive Cardiomyopathy
